Concepedia

Christoph Wohlkoenig

CW

Statistics

Publications

6

Citations

441

H-Index

6

Active since

2008

Affiliations

Medical University of Graz(Current)

Ludwig Boltzmann Institute for Lung Vascular Research

Christoph Wohlkoenig is an author at Medical University of Graz specializing in radiation oncology, lung cancer, and medicine.

Top concepts

Publications per year

2008–2017

6

Publications

6

PCK2 activation mediates an adaptive response to glucose depletion in lung cancer

Katharina Leithner, Andelko Hrzenjak, Martin Trötzmüller et al. · Oncogene · 2014 · 202 citations

, , +9

Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization

Carina Fischer, Katharina Leithner, Christoph Wohlkoenig et al. · Molecular Cancer · 2015 · 74 citations · Full text

Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells

Christoph Wohlkoenig, Katharina Leithner, Alexander Deutsch et al. · Cancer Letters · 2011 · 59 citations

, , +11

Peroxisome Proliferator–Activated Receptor–β/δ, the Acute Signaling Factor in Prostacyclin-Induced Pulmonary Vasodilation

Yingji Li, Michelle Connolly, Chandran Nagaraj et al. · American Journal of Respiratory Cell and Molecular Biology · 2011 · 46 citations

Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy

Katharina Leithner, Elvira Stacher, Robert Wurm et al. · Lung Cancer · 2008 · 33 citations

, , +6

1–5 of 6